Spectracef (cefditoren pivoxil), a new third generation cephalosporin

October 2001

You'll soon see Spectracef (cefditoren pivoxil), a new third generation cephalosporin from TAP Pharmaceuticals.

It will be used in patients 12 and older for bronchitis...pharyngitis...tonsillitis...and uncomplicated skin infections.

Spectracef has been compared to penicillin, Ceftin (cefuroxime), Duricef (cefadroxil), and Biaxin (clarithromycin).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Electronic Rxs are coming
Diabetes new rapid-acting insulin analog called Novolog (insulin aspart)
Diabetes stronger warnings about heart failure with Avandia
Diabetes more aggressive guidelines for diabetes screening and management
Migraine Midrin is now a Schedule IV controlled drug
withdrawal symptoms when patients stop antidepressants
Men's Health whether Viagra (sildenafil) loses its effectiveness over time
Men's Health which BPH patients should get Proscar or an alpha-blocker
Tuberculosis Remicade and Enbrel could lead to increases in tuberculosis (TB).
Tuberculosis using rifampin WITH pyrazinamide for latent tuberculosis
Pediatrics if it's okay to drink a little alcohol occasionally during pregnancy
Pediatrics amantadine for children with autism or other developmental disabilities
Infectious Diseases Spectracef (cefditoren pivoxil), a new third generation cephalosporin
Hematology & Oncology new IV bisphosphonate called Zometa (zoledronic acid)
Hematology & Oncology glutamine for mucositis caused by chemotherapy
Hematology & Oncology Our CE Booklets on natural medicines
concerns about bioterrorism